XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Stockholders' Equity

10. Stockholders’ Equity

 

Common Stock

 

The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share (further details as of the date of these financial statement were issued or were available to be issued are provided under the heading Amendment to Certificate of Incorporation in Note 13).

 

Common Stock Warrants

 

The Company issued warrants to purchase shares of the Company’s common stock to MDB Capital Group, LLC (the “MDB Warrants”), L2 Capital, LLC (the “L2 Warrants”), Strome Mezzanine Fund LP (the “Strome Warrants”), and B. Riley Financial, Inc. (the “B. Riley Warrants”) in connection with various financing transactions (collectively, the “Financing Warrants”).

 

The Financing Warrants outstanding and exercisable as of September 30, 2020 are summarized as follows:

 

              Outstanding        
    Exercise     Expiration   Classified as Derivative Liabilities    

Classified

within Stockholders’ Equity

    Total Exercisable  
    Price     Date   (Shares)     (Shares)     (Shares)  
MDB Warrants   $ 0.20      November 4, 2021     -       327,490       327,490  
Strome Warrants     0.50      June 15, 2023     1,500,000       -       1,500,000  
B. Riley Warrants     1.00      October 18, 2025     875,000       -       875,000  
MDB Warrants     1.15      October 19, 2022     -       119,565       119,565  
MDB Warrants     2.50      October 19, 2022     -       60,000       60,000  
Total outstanding and exercisable                 2,375,000       507,055       2,882,055  

 

The intrinsic value of exercisable but unexercised in-the-money stock warrants as of September 30, 2020 was $810,968, based on a fair market value of the Company’s common stock of $0.89 per share on September 30, 2020.